Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children
Clinical trial NCT03596801 · COMPLETED
Trial details
- NCT number
- NCT03596801
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-29
- Primary completion
- 2024-04-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.